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Saturated fatty acids contribute to β­cell dysfunction in 
the onset of type 2 diabetes mellitus. Cellular responses to 
lipotoxicity include oxidative stress, endoplasmic reticulum 
(ER) stress, and blockage of autophagy. Palmitate induces 
ER Ca2+ depletion followed by notable store­operated Ca2+ 
entry. Subsequent elevation of cytosolic Ca2+ can activate 
undesirable signaling pathways culminating in cell death. 
Mitochondrial Ca2+ uniporter (MCU) is the major route for 
Ca2+ uptake into the matrix and couples metabolism with 
insulin secretion. However, it has been unclear whether 
mitochondrial Ca2+ uptake plays a protective role or 
contributes to lipotoxicity. Here, we observed palmitate 
upregulated MCU protein expression in a mouse clonal β­cell, 
MIN6, under normal glucose, but not high glucose medium. 
Palmitate elevated baseline cytosolic Ca2+ concentration 
([Ca2+]i) and reduced depolarization­triggered Ca
2+ influx 
likely due to the inactivation of voltage­gated Ca2+ channels 
(VGCCs). Targeted reduction of MCU expression using RNA 
interference abolished mitochondrial superoxide production 
but exacerbated palmitate­induced [Ca2+]i overload. 
Consequently, MCU knockdown aggravated blockage of 
autophagic degradation. In contrast, co­treatment with 
verapamil, a VGCC inhibitor, prevented palmitate­induced 
basal [Ca2+]i elevation and defective [Ca
2+]i transients. 
Extracellular Ca2+ chelation as well as VGCC inhibitors effec­
tively rescued autophagy defects and cytotoxicity. These 
observations suggest enhanced mitochondrial Ca2+ uptake via 
MCU upregulation is a mechanism by which pancreatic β­cells 
are able to alleviate cytosolic Ca2+ overload and its detrimental 
consequences.
Keywords: cytosolic Ca2+ overload, lipotoxicity, mitochondrial 
Ca2+ uniporter, oxidative stress, pancreatic β-cell
INTRODUCTION
The common features of type 2 diabetes mellitus (T2DM) 
include insulin resistance and pancreatic β-cell deterioration. 
The latter determines the onset of diabetes (Rorsman and 
Ashcroft, 2018). A number of studies show excessive free fat-
ty acids (FFAs) contribute to β-cell dysfunction and cell death. 
Palmitate, stearate, and oleate are the major FFAs in human 
plasma (Hagenfeldt et al., 1972). When isolated human islets 
are exposed to high palmitate and high glucose, β-cells show 
endoplasmic reticulum (ER) dilation, swollen mitochondria, 
several enlarged autophagic vacuoles, and distorted nuclei 
(Martino et al., 2012). These morphologic changes result 
from lipotoxic pathways in which Ca2+ and reactive oxygen 
species (ROS) play key roles. Consistent with these mecha-
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nistic findings, the Paris Prospective Study reports increased 
plasma FFA concentration is one of independent risk factors 
of T2DM in subjects with a history of impaired glucose toler-
ance (Charles et al., 1997). Higher fasting FFA concentrations 
are associated with decreased insulin secretion after an oral 
glucose load in both children and adults (Salgin et al., 2012).
 Palmitate is known to induce oxidative stress via effects 
on multiple metabolic pathways. These include increased 
mitochondrial FFA oxidation, ceramide-disrupted electron 
transport through complex I and III, misfolded protein-in-
duced ROS generation via ER oxidoreductin 1α (ERO-1α) and 
protein disulfide isomerase (PDI), and cytosolic diacylglycer-
ol-protein kinase C (PKC)-NADPH oxidase pathway (Ly et al., 
2017; Oh et al., 2018). Oxidative stress is associated with ER 
Ca2+ release and store depletion (Eletto et al., 2014). Since 
protein folding machinery requires high luminal Ca2+, ER Ca2+ 
depletion accumulates misfolded proteins, which then trig-
ger ER stress responses (Back and Kaufman, 2012). Several 
studies emphasize ER Ca2+ loss and ER stress as causative 
factors in β-cell death (Cnop et al., 2010; Cunha et al., 2008; 
Karaskov et al., 2006; Lee et al., 2010). However, fewer stud-
ies look into palmitate-elicited Ca2+ dyshomeostasis in cytosol 
and other organelles, e.g., mitochondria and lysosomes. 
Uncontrolled elevation of cytoplasmic Ca2+ concentration 
([Ca2+]i) may trigger many undesirable signaling pathways, 
including PKC, Ca2+/calmodulin-dependent protein kinase IV, 
c-Jun N-terminal kinase, and mitogen-activated protein ki-
nase, which are followed by activation of transcription factors 
such as ATF2, CEBP/δ, CREB, Egr-1, and CHOP (da Cunha 
et al., 2015). Cytosolic Ca2+ overload also activates calpains, 
caspases, proteases, phosphatases, and endonucleases, 
which then trigger nitrosative and oxidative stress, lipid per-
oxidation, and mitochondrial dysfunction resulting in apopto-
sis (Carafoli, 2002; Szydlowska and Tymianski, 2010).
 Increased [Ca2+]i can be sequestered and dispersed by 
active mitochondria through mitochondrial Ca2+ uniporter 
(MCU) (De Stefani et al., 2015). MCU transports Ca2+ into 
the mitochondrial matrix driven by dissipation of the electrical 
gradient across the inner mitochondrial membrane and this 
accelerates mitochondrial metabolic flux and ATP synthesis. 
In insulin-secreting cells, MCU-mediated Ca2+ uptake plays 
a crucial role in coupling metabolism and insulin secretion 
(Quan et al., 2015; Tarasov et al., 2012). In mitochondria-as-
sociated ER membrane, MCU transports released Ca2+ from 
the ER to the mitochondrial matrix (Arruda and Hotamisligil, 
2015). Oxidative stress augments this Ca2+ transport and 
leads to excessive matrix Ca2+ accumulation and cytotoxicity 
(Choi et al., 2017). Therefore, mitochondrial Ca2+ uptake has 
a double-edged consequences; the beneficial effect from 
sequestrating and relieving [Ca2+]i overload and the detri-
mental action of matrix Ca2+ burden resulting in permeability 
transition pore opening and cytochrome c release. This is an 
interesting point worth investigating in the pathogenesis of 
β-cell lipotoxicity.
 This study clarifies the role of mitochondrial Ca2+ uptake via 
MCU in insulin-secreting cells experiencing lipotoxicity. Tar-
geted reduction of MCU expression decreased mitochondrial 
ROS generation by palmitate but exacerbated both cytosolic 
Ca2+ overload and defective autophagic degradation. Surpris-
ingly, we found palmitate upregulated MCU expression and 
thus enabled increased mitochondrial Ca2+ sequestration. 
This compensatory mechanism disappeared under high glu-
cose condition. Attenuation of [Ca2+]i overload by inhibiting 
Ca2+ influx protected palmitate-treated cells from autophagic 
blockage and cytotoxicity. These results suggest a novel com-
pensatory mechanism in β-cells that protects against lipotox-
icity and that is mediated by MCU maintenance of cytosolic 
Ca2+ homeostasis.
MATERIALS AND METHODS
Reagents
All chemicals were purchased from Sigma-Aldrich (USA), un-
less otherwise stated. Krebs-Ringer bicarbonate buffer (KRBB) 
solution contains (mM): 5.5 glucose, 0.5 MgSO4, 3.6 KCl, 0.5 
NaH2PO4, 2 NaHCO3, 140 NaCl, 1.5 CaCl2, 10 HEPES, and pH 
7.4 titrated with NaOH. Palmitate (#P9767; Sigma-Aldrich) 
was conjugated with bovine serum albumin (BSA) (#A6003; 
Sigma-Aldrich) in a molar ratio of 5.5:1 as described in (Xu et 
al., 2015).
Cell culture
Mouse insulinoma MIN6 cells (RRID:CVCL_0431) were 
grown in 5.5 mM glucose Dulbecco’s modified Eagle’s me-
dium (DMEM) (#11885-084; Thermo Fisher Scientific, USA) 
supplemented with 10% fetal bovine serum (FBS) (#16000-
044; Thermo Fisher Scientific), 100 IU/ml penicillin, 100 µg/
ml streptomycin and 50 µM β-mercaptoethanol at 37°C with 
5% CO2. Before experiments, cells were seeded into corre-
sponding plates and incubated overnight. Culture medium 
was then exchanged for either 5.5, 11, or 25 mM glucose 
DMEM with 1% FBS followed by the addition of palmitate or 
BSA. Experiments were performed with cells passaged 26-30 
times.
Plasmid transfection
As a ER luminal Ca2+ fluorescent reporter, pCAG G-CEPIA1er 
was a gift from Franck Polleux (Addgene plasmid #105012; 
http://n2t.net/addgene:105012; RRID:Addgene_105012). 
Tandem fluorescent LC3 reporter, ptfLC3 was a gift from 
Tamotsu Yoshimori (Addgene plasmid #21074; http://n2t.
net/addgene:21074; RRID:Addgene_21074). In the acidic 
environment of lysosomes, GFP is degraded but mRFP is not. 
Yellow and red LC3 puncta then represent autophagosomes 
and autophagolysosomes, respectively (Kimura et al., 2007). 
Approximately 6-8 h after cell seeding at 70-90% confluen-
cy, cells were transiently transfected with the plasmid using 
X-tremeGENE HP DNA Transfection Reagent (#6366236001; 
Roche, Germany) and Opti-MEM I Reduced Serum Medium 
(#31985-062; Thermo Fisher Scientific) as diluent according 
to the manufacturer’s protocol.
Confocal microscopy
Cells transfected with ptfLC3 were treated with palmitate or 
BSA followed by fixation with 4% paraformaldehyde for 15 
min at room temperature in the dark. Images were captured 
using a confocal microscope (LSM 800; Zeiss, Germany) and 
its software (ZEN 2.3). Yellow and red puncta were quan-
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tified using ImageJ software (National Institutes of Health 
[NIH]; https://imagej.nih.gov/ij/) and red and green puncta 
were colocalized programmatically with a macro (https://
imagejdocu.tudor.lu/plugin/analysis/colocalization_analysis_
macro_for_red_and_green_puncta/start) (Satir and Pamplie-
ga, 2016).
Small interfering RNA (siRNA) transfection
Mouse MCU (siGENOME; #062849-01) and negative control 
(#SN-1002) siRNAs were purchased from Dharmacon (USA) 
and Bioneer (Korea), respectively. Cells were seeded on to a 
6-well plate 24 h before siRNA transfection. Before the trans-
fection, cells were washed twice with PBS and maintained 
in DMEM. Transfection was conducted using OptiMEM and 
Dharmafect 1 transfection reagent (#T-2001-03; Dharma-
con) following the manufacturer’s guideline. Twenty-four 
hours after transfection, OptiMEM was replaced by complete 
medium. Cells were maintained 72 h before treatment with 
palmitate.
Western blot analysis
Cells were seeded on to a 6-well plate followed by treatment 
of palmitate with or without drugs as indicated. Cells were 
washed three times with cold PBS, lysed using cold RIPA buf-
fer (#89900; Thermo Fisher Scientific) supplemented with 
protease and phosphatase inhibitors (#5892791001 and 
#4906837001, respectively; Roche), and centrifuged (17,000 
rpm, 30 min). Supernatants were run on SDS-PAGE. Proteins 
were electroblotted on to polyvinylidene difluoride mem-
branes (Merck Millipore, USA), blocked with either 5% BSA 
or 6% skim milk for 1 h at room temperature, and incubated 
with primary antibodies overnight at 4°C. The following pri-
mary antibodies were used: phospho-PERK (Thr980; #3179), 
total PERK (#3192), phospho-eIF2α (Ser51; #3597), total 
eIF2α (#5324), CHOP (#2895), cleaved caspase-3 (#9661), 
MCU (#14997), VDAC (#4866), LC3A/B (#4108), and p62 
(#5114) from Cell Signaling Technology (USA); total OX-
PHOS antibody cocktail (#ab110413) and β-actin (#ab6276) 
from Abcam (UK); GAPDH (#sc-47724) from Santa Cruz 
Biotechnology (USA). All antibodies were applied diluted in 
buffer containing 0.1% Tris-buffered saline and Tween 20 
(TBST) with 5% BSA. Membranes were washed with TBST 
four times (5 min/time), and then incubated with horserad-
ish peroxidase-linked secondary antibody against rabbit or 
mouse IgG (#31460 or #31450, respectively; Thermo Fisher 
Scientific) supplemented with 6% skim milk for 1 h at room 
temperature. Membranes were washed again with TBST 
five times and then developed using ECL solution (Luminata 
Forte, #WBLUF0100; Millipore Corp., USA). Immunoreactive 
bands were visualized by Chemi Doc XRS+ imaging system 
and quantified using Image Lab 6.0 (Bio-Rad, USA).
MTT assay
MIN6 cells were plated at 5 × 104 cells/well in a 96-well plate. 
Cells pre-treated for 30 min with drugs were then co-incubat-
ed with palmitate or control BSA for 24 h. MTT solution was 
prepared by dissolving 3-[4,5-dimethylthiazol-2-yl]-2,5-diphe-
nyl tetrazolium bromide (#M2128; Sigma-Aldrich) in fresh 
DMEM medium at 0.5 mg/ml. MTT assay was initiated by 
replacing culture medium with 100 µl of MTT solution. The 
plate was wrapped in foil and placed in an incubator for 2 h. 
After careful removal of medium to avoid cell detachment, 
100 µl of DMSO was added to each well to dissolve formazan 
crystals. The plate was then gently swirled for 10 min and the 
absorbance value of each well was measured at 570 nm and 
650 nm (reference) by Epoch Microplate Spectrophotometer 
(Bio-Tek, USA).
Apoptotic assay
The number of cytoplasmic mono- and oligo-nucleosome-as-
sociated histone-DNA complexes in cell lysates was measured 
by sandwich ELISA assay (Cell Death Detection ELISA Plus kit, 
#11774425001; Roche). MIN6 cells (5 × 104 cells/well) were 
seeded into 96-well plate. Cells were pre-treated with drug 
for 30 min then co-incubated with 500 µM palmitate or BSA 
for 24 h. The assay was performed by adding 200 µl of kit 
lysis buffer to each well and incubating for 30 min at room 
temperature. After centrifugation, 20 µl of supernatant was 
collected, and manufacturer instructions were followed. After 
a 5 min incubation with a peroxidase substrate, absorbance 
values were measured at 405 nm and 490 nm (reference) by 
Epoch Microplate Spectrophotometer.
Intracellular and ER Ca2+ measurement
MIN6 (3 × 104) cells suspended in 500 µl of complete medi-
um were seeded on to 12 mm L-poly-lysine coated coverslips 
embedded in a 4-well plate then treated with palmitate 
(500 µM, 24 h) or BSA. To measure cytosolic Ca2+, cells were 
incubated with 5 µM Fura-2 AM dissolved in KRBB for 1 h 
at room temperature, washed three times with KRBB, and 
perfused with free-Ca2+ KRB buffer in the presence of 200 
µM sulfinpyrazone unless noted otherwise. The chamber was 
placed into the IX-73 inverted microscope platform (Olym-
pus, Japan) with a camera attachment (Prime-BSI CMOS 
camera; Teledyne Photometrics, USA) and an illuminator 
(pe-340Fura; CoolLED, UK). The fluorophore was alternately 
excited at 340 and 380 nm while emission was recorded at 
510 nm using MetaFluor 6.1 (Molecular Devices, USA). Back-
ground-subtracted 340/380 Fura-2 AM ratio reflecting [Ca2+]
i changes was calculated. At the end of each experiment, 10 
µM ionomycin dissolved in 1.5 mM Ca2+ KRBB was added to 
induce a maximal ratio for comparison between control and 
palmitate-treated cells. For ER Ca2+ measurement, we trans-
fected cells with G-CEPIA1er 48 h before the experiment. 
Fluorescence emission at 535 nm was recorded and analyzed 
following excitation with 488 nm.
ROS measurement
MIN6 (3 × 104) cells were plated on to 12 mm L-poly-lysine 
coated coverslips embedded in a 4-well plate before treat-
ment with palmitate (500 µM, 24 h) or BSA. Cells were incu-
bated either with 2.5 µM CM-H2DCFDA (2′-7′ dichlorofluo-
rescin diacetate) (#C6827; Thermo Fisher Scientific) or 5 µM 
mitoSOX (#M36008; Thermo Fisher Scientific) for 10 min at 
37°C to detect intracellular ROS or mitochondrial superoxide 
production, respectively. Excitation/emission wavelengths 
for DCF and mitoSOX were 490/535 nm and 514/560 nm, 
respectively. Fluorescence intensity was quantified using the 
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IX81 inverted microscope (Olympus) with MetaMorph 6.1 
(Molecular Devices).
Statistical analysis
Data were analyzed in GraphPad Prism 6.01 (GraphPad Soft-
ware, USA) and presented as mean ± SD or SEM if available. 
Representative Ca2+ traces were the average of two or more 
Ca2+ recordings. Cell responses from at least three indepen-
dent experiments were displayed in jitter plots in combination 
with bar graphs. Student’s t-test or one- or two-way ANOVA 
with Bonferroni post-hoc test was used. P values less than 
0.05 were considered statistically significant.
RESULTS
Palmitate elicited Ca2+ and ROS­related pathogenic chang­
es and apoptosis in MIN6 cells
First, we established a cytotoxic dose profile for palmi-
tate in a mouse clonal pancreatic β-cell line, MIN6. Palmi-
tate decreased cell viability, measured by MTT assay, in a 
dose-dependent manner (Fig. 1A). Lipotoxic cell death was 
confirmed by increased apoptotic DNA fragments (Fig. 1B). 
Palmitate markedly elevated intracellular and mitochondrial 
ROS accumulation (Figs. 1C and 1D). In addition, palmitate 
incubation abrogated cyclopiazonic acid (CPA)-induced 
[Ca2+]i response, which reflects ER Ca
2+ content (Figs. 1E 
and 1F). To demonstrate the loss of Ca2+ stores in the ER, 
we measured intraluminal Ca2+ using a fluorescent reporter, 
Fig. 1. Palmitate­induced oxidative stress and ER Ca2+ depletion resulted in ER stress and cell death. (A and B) Effects of different 
doses of palmitate (PA, 24 h) on MTT (A) and apoptotic DNA fragment (B) assays in MIN6 cells. (C and D) PA (500 µM)- or BSA-induced 
cytosolic ROS (C) and mitochondrial superoxide generation (D) measured by using DCF-DA and mitoSOX, respectively. Scale bars = 
10 µm. (E and F) Cytosolic Ca2+ changes by CPA (20 µM), a SERCA inhibitor, in BSA- or PA-treated cells loaded with Fura-2 AM. (G-I) 
Changes in ER Ca2+ content by ATP (100 µM) or CPA in BSA- or PA-treated cells after transfection with CEPIA1er, a ER Ca2+ reporter. FI, 
fluorescence intensity. (J and K) Time kinetics of different ER stress markers during palmitate treatment. (L and M) Effect of mitochondrial 
ROS scavenger, mitoTEMPO (500 nM) on palmitate-induced CHOP and cleaved caspase 3 (L) and apoptotic DNA fragments (M). 
Data represent mean ± SD, except MTT assay data, which show mean ± SEM. Data were collected from more than three independent 
experiments and analyzed by either two-tailed Student’s t-test or one-way ANOVA. ns, not significant; *P < 0.05; **P < 0.01; ***P < 
0.001; ****P < 0.0001.
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G-CEPIA1er. As expected, the majority of control BSA-treat-
ed cells showed the ATP-induced ER Ca2+ release mediated 
by IP3. Subsequent application of CPA completely depleted 
ER Ca2+ stores. Interestingly, heterogeneous responses to ATP 
and CPA were observed among different cells with palmitate 
pre-incubation. One-third of palmitate-treated cells possessed 
an empty ER Ca2+ pool and agonist treatment did not release 
any further ER Ca2+. The remaining two-thirds of cells had 
lower ER Ca2+ and showed a smaller Ca2+ response upon ATP 
stimulation compared to control BSA-treated cells (Figs. 1G-
1I). Depletion of ER Ca2+ stores strongly activated store-oper-
ated Ca2+ entry, especially in cells with completely emptied ER 
Ca2+ pools (Fig. 1G).
 Because ER Ca2+ disturbance has a detrimental effect on 
protein folding (Back and Kaufman, 2012), we investigated 
alterations in the PERK-mediated ER stress response during 
the course of palmitate incubation. Both PERK and eIF2α 
showed early activation, before 12 h of palmitate treatment. 
This was followed by an increase in CHOP expression (Figs. 
1J and 1K). Upregulation of CHOP was concomitant with a 
decrease in phospho-eIF2α, which is a dephosphorylation 
target of CHOP (Novoa et al., 2001). To demonstrate the 
cross-talk between ER stress and oxidative stress, we tested 
ROS scavenger treatment to see if their reduction of oxidative 
stress also reduces the severity of palmitate induced ER stress. 
Indeed, mitoTEMPO, a mitochondria-targeted antioxidant, re-
duced CHOP protein levels and reduced the extent of caspase 
3 activation (Fig. 1L). Furthermore, mitoTEMPO reduced DNA 
fragments indicative of lipotoxic cell death (Fig. 1M).
MCU knockdown did not improve palmitate­induced ER 
stress nor cell death
We have previously reported cellular oxidative stress triggers 
MCU-mediated Ca2+ uptake and ER Ca2+ release in myocytes 
Fig. 2. MCU was upregulated by palmitate while MCU knockdown did not improve ER stress and cell death. (A and B) Representative 
immunoblotting and its quantitation of glucose effect on MCU expression in MIN6 cells. (C and D) Effect of glucose on palmitate (PA)-
induced MCU upregulation. (E and F) Effect of siRNA-mediated MCU knockdown on the expression of VDAC and electron transport 
chain subunits. Complex I (CI): NDUFB8, complex II (CII): SDHB, complex III (CIII): UQCRC2, complex IV (CIV): MTCO1, and complex V (CV): 
ATP5A. (G and H) Effects of MCU knockdown on mitochondrial superoxide production by palmitate treatment. Scale bars = 10 µm. (I 
and J) Effects of MCU knockdown on palmitate-induced cytotoxicity determined by MTT (I) and apoptotic DNA fragment (J) assays. (K-M) 
Effects of MCU knockdown on CHOP and cleaved caspase-3 levels induced by palmitate incubation. Data represent mean ± SD, except 
MTT assay data, which show mean ± SEM. Data were collected from more than three independent experiments and analyzed by either 
two-tailed Student’s t-test or one-way ANOVA. ns, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
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of Drosophila melanogaster (Choi et al., 2017). To under-
stand the role of mitochondrial Ca2+ uptake in glucolipotox-
icity, we first checked MCU protein levels under high glucose 
or palmitate conditions. MCU expression was downregulated 
when cells in normal glucose (5.5 mM) medium were ex-
posed to high glucose (25 mM) for 24 h (Figs. 2A and 2B). 
We then incubated MIN6 cells with palmitate (500 µM) for 
24 h in either 5.5 or 25 mM glucose medium. Interestingly, 
palmitate significantly upregulated MCU protein expression 
under normal glucose medium but not under high glucose, 
while VDAC expression did not vary in either condition (Figs. 
2C and 2D). To elucidate the pathophysiological role of up-
regulated MCU in palmitate-induced lipotoxicity, we reduced 
MCU expression by RNAi targeting, and reduction in protein 
level was confirmed by immunoblotting (Figs. 2E and 2F). 
MCU knockdown led to the downregulation of oxidative 
phosphorylation proteins, a phenomenon that was also pre-
viously demonstrated in a rat β-cell line, INS-1E (Quan et al., 
2015). Silencing of MCU abolished mitochondrial superoxide 
generation in response to palmitate; this suggests a critical 
role for Ca2+ uptake in mitochondrial oxidative stress (Figs. 
2G and 2H). However, MCU knockdown did not rescue cells 
from palmitate-induced cytotoxicity, as estimated by MTT 
and DNA fragments assays (Figs. 2I and 2J). Furthermore, 
MCU silencing did not attenuate palmitate-induced CHOP 
upregulation and caspase 3 cleavage (Figs. 2K-2M). These re-
sults suggest that mitochondrial Ca2+ uptake does not partici-
pate in palmitate-induced cytotoxicity despite its contribution 
Fig. 3. Knockdown of MCU aggravated palmitate­induced cytosolic Ca2+ overload and defective autophagic degradation in MIN6 
cells. (A-C) Representative traces of cytosolic Ca2+ concentration ([Ca2+]i) stimulated by KCl (30 mM) and ionomycin (10 µM) in MIN6 cells 
loaded with Fura-2 AM. Baseline [Ca2+]i levels (B) and the area under the curve (AUC) of KCl-induced [Ca
2+]i changes (C) were compared 
between BSA- or palmitate (PA)-treated cells after transfection with control or MCU siRNA. (D) Immunoblotting and densitometry analysis 
of LC3 by palmitate with or without bafilomycin (Baf A1, 200 nM) added during last 2 h of palmitate incubation. (E) Time-dependent 
effect of palmitate on p62 expression. (F and G) Confocal images and quantitation of red/yellow LC3 puncta in BSA- or PA-treated 
cells after transfection with tandem fluorescent-tagged LC3 (ptfLC3) plasmid. Undigested autophagosomes are increased by palmitate 
determined by the ratio of yellow to red puncta (inset graph in Fig. 3G). (H) Effects of MCU knockdown on palmitate-induced alterations 
in p62 and LC3 proteins. (I and J) Effects of MCU knockdown on red/yellow LC3 puncta in BSA- or PA-treated cells after transfection of 
ptfLC3 plasmid. The ratio of yellow to red puncta is displayed in inset graph of Figure 3J. Data represent mean ± SD. Data were collected 
from more than three independent experiments and analyzed by either two-tailed Student’s t-test or one-way ANOVA. ns, not significant; 
*P < 0.05; **P < 0.01; ****P < 0.0001. Scale bars = 10 µm.
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to ROS generation.
MCU silencing aggravated palmitate­induced cytosolic 
Ca2+ overload and defective autophagic degradation
In a pancreatic β-cell, glucose or other secretagogues increase 
[Ca2+]i via voltage-gated Ca
2+ channel (VGCC)-mediated influx 
or via Ca2+ release from the ER, which triggers insulin granule 
exocytosis (Gilon et al., 2014). The consequent removal of 
secretagogue relieves cytosolic Ca2+ load and returns the cyto-
sol to the resting [Ca2+]i level. We recorded changes in [Ca
2+]i 
using Fura-2 dye in response to high K+-induced depolarization. 
Palmitate slightly elevated basal [Ca2+]i levels but strongly atten-
uated the [Ca2+]i response upon depolarization (Figs. 3A-3C). 
Suppression of mitochondrial Ca2+ uptake by MCU knockdown 
further elevated basal [Ca2+]i in palmitate-treated cells, which 
could be caused by reduced mitochondrial Ca2+ sequestration 
(Figs. 3A and 3B).
 Zummo et al. (2017) showed palmitate decreases au-
tophagic flux in insulin-secreting cells by inhibiting the fu-
sion of lysosomes and autophagosomes. Bafilomycin A1 is 
an inhibitor of lysosomal V-ATPase, which blocks luminal 
acidification and degradation of auophagolysosomes. We 
also observed that the LC3-II/β-actin ratio was elevated in 
palmitate-treated cells but not increased any further during 
bafilomycin A1 treatment, implying the formation of au-
tophagolysosomes was suppressed by palmitate (Fig. 3D). 
Consistent with increases in LC3, p62 protein was increased 
during the treatment with palmitate (Fig. 3E). We further 
Fig. 4. Verapamil prevented palmitate­induced cytosolic Ca2+ overload, defective autophagic flux and lipotoxicity in MIN6 cells. (A) 
Representative traces of cytosolic Ca2+ concentration ([Ca2+]i) stimulated by KCl (30 mM) and ionomycin (10 µM) in MIN6 cells loaded 
with Fura-2 AM. Baseline [Ca2+]i levels (B) and the area under the curve (AUC) of KCl-induced [Ca
2+]i changes (C) in the presence of 
palmitate were compared between vehicle- or verapamil (10 µM)-pretreated cells after transfection with control or MCU siRNA. (D-
G) Effects of EGTA (0.4 mM)- or verapamil-pretreatment on palmitate-induced cytosolic ROS (D and E) and mitochondrial superoxide 
generation (F and G) measured by using DCF-DA and mitoSOX, respectively. (H) Immunoblotting of p62 and LC3 in palmitate-incubated 
cells with verapamil or vehicle pretreatment. (I and J) Confocal images and quantitation of red/yellow LC3 puncta in BSA- or PA-treated 
cells with vehicle- or verapamil pretreatment after transfection with ptfLC3 plasmid. The ratio of yellow to red puncta is displayed in inset 
graph of Fig. 4J). (K and L) Effects of EGTA, nifedipin (10 µM) or verapamil-pretreatment on palmitate-induced cytotoxicity determined by 
MTT (I) and apoptotic DNA fragment (J) assays. Data represent mean ± SD, except MTT assay data, which show mean ± SEM. Data were 
collected from more than three independent experiments and analyzed by either two-tailed Student’s t-test or one-way ANOVA. ns, not 
significant; *P < 0.05; **P < 0.01; ****P < 0.0001. Scale bars = 10 µm.
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examined palmitate-elicited autophagic inhibition by using 
tandem fluorescent-tagged LC3 (ptfLC3) plasmid. Confocal 
microscopy revealed autophagosome and autophagolyso-
some puncta, and these are rendered in yellow and in red, 
respectively. Palmitate drastically increased the average cell 
area covered by yellow puncta while it modestly affected that 
of red puncta (Figs. 3F and 3G). As a result, the ratio of yel-
low to red puncta was significantly higher in palmitate-treat-
ed cells compared to BSA-treated cells (Fig. 3G, inset graph). 
We further estimated the effects of palmitate on autophagic 
flux in MCU-silenced and control cells. Immunoblots revealed 
that MCU ablation did not rescue p62 accumulation during 
lipotoxicity (Fig. 3H). Consistently, the extent of yellow punc-
ta and the ratio of yellow to red puncta in palmitate-treated 
cell were not reduced but instead were augmented by MCU 
knockdown (Figs. 3I and 3J). Collectively, these data suggest 
that upregulation of MCU by palmitate mitigates cellular Ca2+ 
overload and alleviates autophagic block during β-cell lipo-
toxicity.
Attenuation of extracellular Ca2+ influx via VGCC alleviat­
ed Ca2+ overload and cytotoxicity by palmitate
One hypothesis suggests excessive Ca2+ influx from extra-
cellular space through VGCCs could contribute to the pal-
mitate-induced toxicity in insulin-secreting cells (Choi et al., 
2007). Our data also indicate that inhibition of mitochondrial 
Ca2+ sequestration results in detrimental consequences of 
Ca2+ cytotoxicity by palmitate. Hence we next tested wheth-
er attenuating [Ca2+]i overload could relieve the pathologic 
consequences of β-cell lipotoxicity. To reduce VGCC-medi-
ated Ca2+ influx, we exposed cells to a Ca2+ chelator, EGTA, 
or to VGCC inhibitors verapamil or nifedipine. As expected, 
co-treatment with verapamil for 24 h abated basal [Ca2+]i rise 
by palmitate (Figs. 4A and 4B). Preventive action of verapamil 
on [Ca2+]i
 overload was more prominent in MCU silenced cells 
(Fig. 4B). In these experiments, we washed out verapamil 
thoroughly before measuring maximum voltage-gated Ca2+ 
flux, which we induced using high K+. Pre-incubation with 
verapamil ameliorated the [Ca2+]i response to depolarization 
both in control and MCU knockdown cells (Fig. 4C).
 We observed that extracellular Ca2+ chelation with EGTA 
or VGCC inhibition with verapamil suppressed palmitate-in-
duced cytosolic (Figs. 4D and 4E) and mitochondrial (Figs. 4F 
and 4G) ROS production. Moreover, verapamil reduced p62 
accumulation during the entire period of palmitate treatment 
(Fig. 4H). Confocal imaging analysis with tandem fluores-
cent-tagged LC3 transfection revealed that verapamil pre-in-
cubation decreased the number of yellow puncta and the 
ratio of yellow to red puncta in palmitate-treated cells (Figs. 
4I and 4J). Finally, extracellular EGTA and VGCC inhibitors 
each rescued cell viability (Fig. 4K) and prevented apoptotic 
cell death (Fig. 4L). These results suggest that cytosolic Ca2+ 
burden due to extracellular Ca2+ influx is a critical pathogen-
ic mechanism for autophagy defects and β-cell lipotoxicity. 
This Ca2+ overload by palmitate could be compensated by 
MCU-mediated Ca2+ sequestration.
DISCUSSION
In this study, we demonstrated ER Ca2+ release and store 
depletion by palmitate related to oxidative stress. ER Ca2+ 
depletion by palmitate leads to ER stress responses and 
cell death in mouse clonal pancreatic β-cells. These results 
are consistent with reports in other insulin-secreting cells 
(Gwiazda et al., 2009; Hara et al., 2014) and our previous 
observation in mouse podocytes (Xu et al., 2015). Several 
mechanisms have been suggested for palmitate-induced ER 
Ca2+ depletion. Binding to the fatty acid receptor coupled to 
Gq-protein (GPR40) can trigger IP3-mediated ER Ca
2+ release 
(Mancini and Poitout, 2013). Oxidative stress induced by 
palmitate may stimulate ER Ca2+ release channels directly (Li 
et al., 2009) or promote IP3 generation via phospholipase 
Cγ (Weissmann et al., 2012). Released Ca2+ is taken up by 
sarco-/endoplasmic ER Ca2+ ATPase (SERCA) with ATP-con-
suming active processes. However, palmitate is known to de-
crease SERCA expression and activity, consequently reducing 
ER Ca2+ uptake and luminal Ca2+ content (Gustavo Vazquez-
Jimenez et al., 2016; Hara et al., 2014; Zhang et al., 2014). 
Lowered Ca2+ in the ER deteriorates chaperone function. The 
accumulation of misfolded protein further aggravates oxida-
tive stress via ERO-1α and PDI (Tu and Weissman, 2004). This 
positive feedback loop between oxidative stress and ER stress 
could activate pro-apoptotic downstream effectors in β-cell 
lipotoxicity.
 We intended to scrutinize the alterations in ER Ca2+ content 
by using Ca2+ sensing fluorescent protein expressed exclusively 
in the ER lumen. This sensor successfully detected purinocep-
tor-mediated ER Ca2+ release, emptying of Ca2+ stores by ER 
Ca2+ ATPase inhibition, and Ca2+ refilling through store-oper-
ated Ca2+ entry (SOCE). We observed two patterns of ER Ca2+ 
disturbance by palmitate in insulin-secreting cells: (i) marked 
reduction but not depletion and (ii) complete loss of Ca2+ in 
the ER reservoir (Fig. 1G). Particularly, cells with the latter pat-
tern have a steep [Ca2+]i rise upon extracellular Ca
2+ exposure; 
this implies full activation of SOCE. Previously, we observed a 
marked STIM1 oligomerization leading to persistent SOCE acti-
vation by palmitate in mouse podocytes (Xu et al., 2015). Fur-
thermore, VGCC-mediated Ca2+ influx was also triggered by 
palmitate in insulin-secreting cells (Choi et al., 2007). The Ca2+ 
influx through SOCE and VGCC together with ER Ca2+ release 
might result in sustained elevated [Ca2+]i in palmitate-treated 
cells (Gwiazda et al., 2009). Therefore, it is reasonable to infer 
that cytosolic Ca2+ overburden plays a pathogenic role in β-cell 
lipotoxicity.
 In this study, we observed an increase in MCU expression 
induced by palmitate that has not been previously reported as 
far as we know. This upregulation could be a compensatory 
mechanism for cells to handle cytosolic Ca2+ overload in lipo-
toxicity. We directly measured the palmitate-induced eleva-
tion of basal [Ca2+]i and noted that MCU silencing remarkably 
exacerbated this [Ca2+]i burden (Figs. 3A and 3B). Mitochon-
drial Ca2+ uptake via MCU could sequester Ca2+ and relieve 
Ca2+ accumulation in peri-ER microdomains. Mitochondria 
are known to decrease movement and gather at high Ca2+ 
microdomains. Therefore, mitochondria can sequester Ca2+ 
from localized microdomains to avoid cytotoxicity (Yi et al., 
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2004). It has been well known that high glucose exacerbates 
lipotoxicity in a synergistic manner in the progress of T2DM. 
Interestingly, our study showed that a high glucose environ-
ment decreased MCU expression and abated palmitate-me-
diated MCU upregulation. We speculate that high glucose 
eliminates the compensatory mechanism involving MCU and 
causes further serious consequences related to Ca2+ overload 
in β-cell lipotoxicity. This is the first proposal of a hypothesis 
for glucolipotoxicity.
 We observed a significant reduction in mitochondrial su-
peroxide generation by MCU knockdown, consistent with 
results from many other studies (Panahi et al., 2018; Ren et 
al., 2017; Tomar et al., 2019). This reduction could be at-
tributed to the decrease in mitochondrial metabolism related 
to suppressed TCA cycle dehydrogenases and NADH shuttle 
system, which is sensitive to matrix Ca2+ (Denton, 2009). In 
addition, MCU knockdown correlates with downregulation 
of electron transport chain proteins (Fig. 2E), and this in turn 
could also decrease superoxide production. Unexpectedly, 
however, palmitate-induced ER stress and apoptosis were 
not prevented nor aggravated by MCU silencing. The ratio of 
yellow to red puncta from tandem fluorescent-tagged LC3 
also became substantially higher in palmitate-treated MCU 
knockdown cells, indicating a possibly worsened defect in 
autophagolysosome formation (Park et al., 2014). Increased 
p62 accumulation upon MCU silencing supports the notion 
of deterioration in blocking autophagy. It is conceivable the 
benefits of attenuating mitochondrial Ca2+ uptake were off-
set by the negative consequences of impaired cytosolic Ca2+ 
clearance. Notably, all these pathologic alterations in palmi-
tate-treated cells were rescued by agents that reduce Ca2+ 
influx from extracellular compartments, e.g., EGTA or VGCC 
inhibitors such as verapamil and nifedipine (Fig. 4). Our find-
ings are consistent with a previous report that cytosolic Ca2+ 
overload impedes the fusion between autophagosomes and 
lysosomes in HepG2 cells (Park and Lee, 2014).
 In pancreatic β-cells, ATP-sensitive K+ channel (KATP)-de-
pendent [Ca2+]i increase via VGCC is an important signal for 
glucose-stimulated insulin secretion (Wollheim and Maechler, 
2002). In this study, depolarization-induced [Ca2+]i increase 
was blunted by palmitate in MIN6 cells (Fig. 3A), and cells in 
this state displayed impaired insulin secretion upon nutrient 
stimulation. It has been known that [Ca2+]i increase via VGCCs 
can suppress itself due to Ca2+-dependent inactivation (Haack 
and Rosenberg, 1994). We infer that elevated [Ca2+]i levels 
under lipotoxic conditions could inactivate VGCC directly and 
suppress KATP-dependent Ca
2+ signal generation for insulin se-
cretion. This may be the pathogenic mechanism responsible 
for insufficient insulin secretion and glucose intolerance in 
T2DM patients. Surprisingly, pretreatment of verapamil effec-
tively recovered not only palmitate-induced [Ca2+]i overload 
but also restored depolarization-triggered [Ca2+]i
 response to 
normal. Preventive treatment with verapamil on β-cell lipotox-
icity might result from beneficial actions of [Ca2+]i regulation, 
making verapamil an effective preventive or therapeutic tar-
get for T2DM.
 We demonstrated in this study that mitochondrial Ca2+ 
uptake via MCU upregulation could be an essential com-
pensatory mechanism whereby cells alleviate cytosolic Ca2+ 
overload. Therefore, decreased mitochondrial Ca2+ seques-
tration due to mitochondrial dysfunction may aggravate 
palmitate-induced autophagy defects. Based on our obser-
vations, we suggest cytosolic Ca2+ overload in lipotoxicity 
could be relieved by i) suppressing Ca2+ influx, ii) accelerating 
mitochondrial Ca2+ clearance, or iii) enhancing Ca2+ recycling 
into the ER. Further investigation related to maintaining Ca2+ 
homeostasis may provide the best strategy against pancreatic 
β-cell failure and metabolic diseases.
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